Product NDC: | 10019-027 |
Proprietary Name: | Midazolam Hydrochloride |
Non Proprietary Name: | Midazolam Hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; Midazolam Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-027 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075243 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100304 |
Package NDC: | 10019-027-08 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-027-08) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-027-59) |
NDC Code | 10019-027-08 |
Proprietary Name | Midazolam Hydrochloride |
Package Description | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-027-08) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-027-59) |
Product NDC | 10019-027 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Midazolam Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100304 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | MIDAZOLAM HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |